Approval · Notice of Compliance 22050 · 2019
A180: Notice of Compliance 22050
Issued April 9, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22050
- Date
- April 9, 2019
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of an alternate drug manufacturing and testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| A180 | 02261200 | Marketed |
Medicinal ingredients
- DANOFLOXACIN MESYLATE 180 MG per ML